Divi's Laboratories' share price rose over 5% after Citi maintained a 'Buy' rating, citing a 19% upside potential. The stock reached Rs 6,255 intraday and closed at Rs 6,225, up 5.07%. Citi highlighted Divi's capacity addition and potential as a primary supplier, with expectations of over $800 million in GLP-1 revenue by 2030.
Read more at MoneycontrolAd
Ad